Malhotra, Shelly
28  results:
Search for persons X
?
1

Cost-effectiveness of broadly neutralizing antibodies for i..:

Alba, Christopher ; Malhotra, Shelly ; Horsfall, Stephanie...
info:eu-repo/semantics/altIdentifier/doi/10.1101/2023.11.06.23298184.  , 2023
 
?
5

Cost-effectiveness of broadly neutralizing antibodies for i..:

Alba, Christopher ; Malhotra, Shelly ; Horsfall, Stephanie...
info:eu-repo/semantics/altIdentifier/doi/10.1101/2023.11.06.23298184.  , 2023
 
?
6

Antibodies for HIV prevention: the path forward:

Malhotra, Shelly ; Baggaley, Rachel ; Lynch, Sharonann...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191127/.  , 2023
 
?
9

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HI..:

Bozzani, Fiammetta M ; Terris-Prestholt, Fern ; Quaife, Matthew...
https://researchonline.lshtm.ac.uk/id/eprint/4668362/1/Bozzani-etal-2022-Costs_and_Cost%E2%80%91Efectiveness_of_Biomedical_Non%E2%80%91Surgical_HIV_Interventions.pdf.  , 2022
 
?
11

Cost-effectiveness of bedaquiline, pretomanid and linezolid..:

Gomez, Gabriela Beatriz ; Siapka, Mariana ; Conradie, Francesca...
https://researchonline.lshtm.ac.uk/id/eprint/4664361/1/Cost-effectiveness%20of%20bedaquiline,%20pretomanid%20and%20linezolid%20for%20treatment%20of%20extensively%20drug-resistant%20tuberculosis%20in%20Sout.pdf.  , 2021
 
?
12

The cost and cost-effectiveness of novel tuberculosis vacci..:

Allison Portnoy ; Rebecca A. Clark ; Matthew Quaife...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873163/?tool=EBI.  , 2023
 
1-15